Psyence Group Inc
CNSX:PSYG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (16.5), the stock would be worth CA$-2.79 (2 421% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.7 | CA$0.12 |
0%
|
| Industry Average | 16.5 | CA$-2.79 |
-2 421%
|
| Country Average | 22 | CA$-3.71 |
-3 189%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
P
|
Psyence Group Inc
CNSX:PSYG
|
1.9m CAD | -0.7 | -0.2 | |
| US |
|
Morgan Stanley
NYSE:MS
|
301B USD | -18.1 | 17.2 | |
| US |
|
Goldman Sachs Group Inc
NYSE:GS
|
272.5B USD | -3.4 | 15.9 | |
| EG |
|
EFG Hermes Holdings SAE
LSE:EFGD
|
167.9B USD | 0 | 2 248.9 | |
| US |
|
Charles Schwab Corp
NYSE:SCHW
|
161B USD | -17.9 | 17.8 | |
| US |
|
Interactive Brokers Group Inc
NASDAQ:IBKR
|
136.5B USD | 11.5 | 131.5 | |
| US |
|
Robinhood Markets Inc
NASDAQ:HOOD
|
66.4B USD | 32.8 | 35.3 | |
| CN |
|
CITIC Securities Co Ltd
SSE:600030
|
403.4B CNY | 3 | 13.9 | |
| CN |
|
Guotai Junan Securities Co Ltd
SSE:601211
|
284.2B CNY | 1.8 | 10.4 | |
| US |
|
Raymond James Financial Inc
NYSE:RJF
|
30.8B USD | 5.5 | 14.4 | |
| US |
|
LPL Financial Holdings Inc
NASDAQ:LPLA
|
25.5B USD | 55.3 | 29.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.2 |
| Median | 22 |
| 70th Percentile | 36 |
| Max | 116 589.8 |
Other Multiples
Psyence Group Inc
Glance View
Psyence Group, Inc. is a science-led global psychedelic platform, led by experts in neurology, neuroscience and drug development. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-01-27. The firm builds and operates commercial psilocybin cultivation and production facilities. The company offers natural psilocybin for the long-term treatment of psychological trauma and its mental health consequences. The Company’s natural psychedelics are cultivated in Lesotho. The company focuses on the scientific research and development of psilocybin medical products for research institutions, clinics and regulatory-compliant psilocybin. The company operates across Toronto, Canada; Washington District of Columbia (DC), United States of America; Cape Town, South Africa; Kolojane, Kingdom of Lesotho; Kingston, Jamaica; London United Kingdom; Sydney, Australia and Sao Paulo, Brazil.
